Insurers sue ‘pharma bro’ Martin Shkreli, company for alleged price gouging

BioPharma, biopharma nl, Blue Cross and Blue Shield of Minnesota, Daily, Daraprim, hike, lawsuit, Legal, Martin Shkreli, News, Payers, price, SYN, Top Story, Turing Pharmaceuticals, Vyera Pharmaceuticals / March 9, 2021

Blue Cross and Blue Shield of Minnesota has filed a class-action lawsuit — on behalf of itself and insurers from 30-plus states — against Martin Shkreli and Vyera Pharmaceuticals. The suit alleges the defendants intentionally monopolized the market for Daraprim to raise the price of the drug by more than 4,000%.